Organon & Co (OGN)
19.06
+0.45
(+2.42%)
USD |
NYSE |
May 01, 15:01
Organon Market Cap: 4.872B for May 1, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 30, 2024 | 4.757B |
April 29, 2024 | 4.832B |
April 26, 2024 | 4.742B |
April 25, 2024 | 4.709B |
April 24, 2024 | 4.783B |
April 23, 2024 | 4.734B |
April 22, 2024 | 4.601B |
April 19, 2024 | 4.555B |
April 18, 2024 | 4.566B |
April 17, 2024 | 4.568B |
April 16, 2024 | 4.548B |
April 15, 2024 | 4.527B |
April 12, 2024 | 4.461B |
April 11, 2024 | 4.673B |
April 10, 2024 | 4.642B |
April 09, 2024 | 4.706B |
April 08, 2024 | 4.642B |
April 05, 2024 | 4.566B |
April 04, 2024 | 4.568B |
April 03, 2024 | 4.578B |
April 02, 2024 | 4.635B |
April 01, 2024 | 4.729B |
March 28, 2024 | 4.806B |
March 27, 2024 | 4.717B |
March 26, 2024 | 4.632B |
Date | Value |
---|---|
March 25, 2024 | 4.555B |
March 22, 2024 | 4.545B |
March 21, 2024 | 4.678B |
March 20, 2024 | 4.640B |
March 19, 2024 | 4.586B |
March 18, 2024 | 4.553B |
March 15, 2024 | 4.673B |
March 14, 2024 | 4.694B |
March 13, 2024 | 4.742B |
March 12, 2024 | 4.671B |
March 11, 2024 | 4.688B |
March 08, 2024 | 4.717B |
March 07, 2024 | 4.660B |
March 06, 2024 | 4.594B |
March 05, 2024 | 4.538B |
March 04, 2024 | 4.446B |
March 01, 2024 | 4.489B |
February 29, 2024 | 4.451B |
February 28, 2024 | 4.558B |
February 27, 2024 | 4.612B |
February 26, 2024 | 4.512B |
February 23, 2024 | 4.729B |
February 22, 2024 | 4.742B |
February 21, 2024 | 4.737B |
February 20, 2024 | 4.727B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.799B
Minimum
Nov 16 2023
9.980B
Maximum
Mar 02 2022
6.715B
Average
7.171B
Median
Market Cap Benchmarks
Merck & Co Inc | 328.91B |
Alnylam Pharmaceuticals Inc | 19.06B |
Amgen Inc | 149.45B |
Biogen Inc | 31.71B |
Pacira BioSciences Inc | 1.254B |
Market Cap Related Metrics
PE Ratio | 4.765 |
PS Ratio | 0.7799 |
PEG Ratio | 0.4173 |
Price to Free Cash Flow | 9.079 |
Price | 19.06 |
Earnings Yield | 20.99% |
PEGY Ratio | 0.2733 |
Operating PE Ratio | 3.681 |
Normalized PE Ratio | 4.392 |